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OBJECTIVES This project evaluated if by focusing on process changes and tool use rather than key indicator rates, the
use of evidence-based therapies in patients with acute myocardial infarction (AMI) would increase.
BACKGROUND The use of tools designed to improve quality of care in the American College of Cardiology AMI
Guidelines Applied in Practice Pilot Project resulted in improved adherence to evidence-based
therapies for patients, but overall, tool use was modest.
METHODS The current project, implemented in five hospitals, was modeled after the previous project, but
with greater emphasis on tool use. This allowed early identification of barriers to tool use and
strategies to overcome barriers. Main outcome measures were AMI quality indicators in
pre-measurement (January 1, 2001 to June 30, 2001) and post-measurement (December 15, 2001
to March 31, 2002) samples.
RESULTS One or more tools were used in 93% of patients (standard orders 82%, and discharge document
 47%). Tool use was associated with significantly higher adherence to most discharge quality
indicator rates with increases in aspirin, angiotensin-converting enzyme inhibitors, and smoking
cessation and dietary counseling. Patients undergoing coronary artery bypass grafting (CABG)
had low rates of discharge indicators. Patients undergoing percutaneous coronary revascularization
were more likely to receive evidence-based therapies.
CONCLUSIONS These data validate the results of the pilot project that quality of AMI care can be improved
through the use of guideline-based tools. Identifying and overcoming barriers to tool use led to
substantially higher rates of tool use. The low rates of adherence to quality indicators in patients
undergoing CABG suggest that these patients should be particularly targeted for quality
improvement efforts. (J Am Coll Cardiol 2004;43:2166–73) © 2004 by the American College
of Cardiology FoundationT
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ilot Project provided a foundation for future projectsaimed
t enhancing the quality of care for patients with acute
yocardial infarction (AMI) (1,2) and other cardiovascular
onditions. The ACC GAP Pilot Project was a response to
teady demands on health care providers to increase the
are, and therefore required no special funding on the part of this contractor. Ideas
nd contributions to the authors concerning experience in engaging with issues
resented are welcomed.
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June 16, 2004:2166–73 Improving Quality of AMI Careuality of AMI care. The pilot project, implemented at 10
outheast Michigan hospitals, incorporated national guide-
ines (3) into care processes by creating clinical care tools
nd systems focused on the caregivers and patients that
einforced adherence to evidenced-based pharmacologic,
ifestyle, and behavioral goals for the care of patients with
MI. This strategy was successful in enhancing the quality
f care of patients with AMI (2). Importantly, evidence of
ool use such as standard admitting orders and a standard
ischarge document was associated with the greatest im-
rovement. In the GAP Pilot Project, clinical care tool use,
ereafter labeled “tool use,” was documented on the chart
nly in one-fourth of the patients (2). These findings argued
or a strategy emphasizing and monitoring tool use, with
ontinuous attempts to identify and overcome barriers to
heir use.
Following the GAP Pilot Project, the Greater Flint
ealth Coalition (GFHC) requested that the ACC support
nother AMI GAP project, aimed at improving AMI care
n the five Flint and Saginaw area hospitals. The ACC
artnered with the GFHC and the Michigan Peer Review
rganization (MPRO), a state quality improvement orga-
ization for the Centers for Medicare & Medicaid Services
CMS). Unlike the GAP Pilot Project, this project focused
n the use and concurrent monitoring of care tools with a
oal of identifying barriers to their use and strategies to
vercome them to maximize quality improvement.
ETHODS
artnership. The ACC AMI GAP Project in Michigan:
lint and Saginaw Expansion, hereafter referred to as the
AP Flint-Saginaw Project, was modeled after the GAP
ilot Project (4). The quality improvement strategies were
urther enhanced by an adaptation of the Institute for
ealthcare Improvement Breakthrough Series Model (5).
e included rapid cycle quality improvement with the
stablishment and support of a collaborative culture of
earning and sharing among hospital teams aimed at in-
reasing the use of the AMI standardized tools. This model
mphasizes brief, iterative strategies targeting specific goals
r barriers in step-by-step improvement. The oversight
eam, including representatives from the partnership orga-
izations (ACC, MPRO, GFHC), designed, coordinated,
Abbreviations and Acronyms
ACC  American College of Cardiology
ACE  angiotensin-converting enzyme
AMI  acute myocardial infarction
CABG  coronary artery bypass graft surgery
CMS  Center for Medicare & Medicaid Services
GAP  Guidelines Applied in Practice
GFHC  Greater Flint Health Coalition
MPRO  Michigan Peer Review Organization
PCI  percutaneous coronary interventionnd implemented the project. Each organization contrib- hted to the project. The ACC provided professional credi-
ility, clinical expertise, and quality improvement expertise
hrough a physician and nurse investigator team. The ACC
urse investigator was the project manager. The GFHC
rovided local ownership and support that increased the
uy-in by the participating hospitals. The GFHC convened
artnership meetings, contributed funding for the project’s
ctivities, and obtained additional funding for the non-
edicare data abstraction and analysis. The MPRO pro-
ided quality improvement and statistical expertise through
project manager and coordinator, and a data analyst. The
PRO managed data collection and analysis of the Medi-
are patients through the CMS’s Sixth Scope of Work.
The project began in July 2001. A physician champion
nd a project leader, usually a nurse with expertise in quality
mprovement, were identified at each hospital. After initial
lanning, a series of educational sessions were held to
upport project implementation. These focused on project
lanning, introduction or hospital kick-off, implementation
f standardized tools, monitoring progress, re-measurement
abstraction of charts after the project had been imple-
ented to determine whether adherence to quality in-
icators had improved), and presentation of the results.
dditionally, ongoing support was provided via phone
onsultations, e-mail communications, and site visits by the
artnership leaders.
roject implementation. Like the GAP Pilot Project
1,2), the GAP Flint-Saginaw Project was a multifaceted
ntervention including a kick-off presentation, customiza-
ion and implementation of a series of care tools or tool kit
ased on the ACC/American Heart Association guidelines
3), leadership by a local physician champion and project
eader at each hospital, grand round site visits, and pre- and
ost-measurement of quality indicators. The project was
ompleted within one year. The physician and nurse leaders
nd the multidisciplinary team at each hospital were ex-
ected to customize and implement the ACC AMI Tool
it that consisted of seven components: 1) AMI standard
rders; 2) clinical pathway (particularly targeting daily
ursing care); 3) pocket guide/pocket card for AMI from
he ACC; 4) patient information form, a one-page docu-
ent describing key milestones in care; 5) AMI-specific
atient discharge form; 6) chart stickers; and 7) hospital
erformance charts which inform each hospital about their
ecent rates for key quality indicators. We emphasized the
se of standard orders and AMI discharge instructions
orms, based on experiences with the GAP Pilot Project
1,2). The five hospitals were already using standard orders.
ospitals were asked to compare their orders with those of
he ACC Tool Kit, and to revise their orders to be
onsistent with the national guidelines. All five hospitals
dopted an AMI discharge tool modeled after the one in the
CC Tool Kit. Grand round site visits at each hospital
erved as the hospital’s kick-off event. At grand rounds, the
oundation and rationale for the project was explained, the
ospital teams introduced their multidisciplinary team,
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Improving Quality of AMI Care June 16, 2004:2166–73xplained their plans and timeline for clinical care tool use
mplementation, showed the customized tools, and clarified
rocess changes. The ACC and MPRO project managers
lso provided in-service educational opportunities particu-
arly targeting those who were unable to attend the grand
ounds.
Based on the lessons learned from the GAP Pilot Project,
he GAP Flint-Saginaw initiative provided consistent and
nhanced support from the ACC physician liaison and
roject manager and the MPRO project manager and
oordinator. This was particularly directed at the quality
mprovement phases of planning, tool use implementation,
onitoring tool use, and re-measurement with a repeating
ocus on tool use and monitoring tool use in all phases of the
roject (Fig. 1). To do this, four group meetings with the
ospital project leaders and various team members were
onvened, as well as frequent e-mail and phone contact.
nhanced mentoring, communication, and collaboration
acilitated early identification of process changes, barriers,
nd resistance to change and the development of new
trategies for a rapid response to barriers experienced by the
ospital teams.
tudy sample and data collection. The impact of the
uality improvement strategies in this project was evaluated
sing measurement of pre-implementation and post-
mplementation adherence to key evidence-based therapies.
he baseline sample was identified using claims with the
nternational Classification of Diseases-Ninth Revision-
linical Modification principal discharge diagnosis code for
MI (410.xx) between January 1, 2001 and June 30, 2001.
atients with codes that designated subsequent episodes of
are (410.x2) were excluded from the study. Data were
bstracted from two groups: cases with Medicare as their
rimary insurance (Medicare group) and patients not having
edicare as their primary insurance (non-Medicare group).
edicare baseline cases were identified from filed CMS
eneficiary claims data, whereas non-Medicare baseline
atients were identified from individual hospitals. A 50%
igure 1. The American College of Cardiology (ACC) Acute Myocardial
nfarction (AMI) Guidelines Applied in Practice Project: Flint and
aginaw Expansion Collaborative Model. GFHC  Greater Flint Health
oalition.andom sample and a 20-case minimum of baseline Medi- Bare cases were selected from each hospital. The non-
edicare sample consisted of a 33% random sample and a
inimum of 20 cases per hospital. From a universe of 728
edicare and 626 non-Medicare cases, 359 and 207 cases
ere abstracted at baseline, respectively. Patients without a
onfirmed AMI were excluded from the study sample,
eaving a total of 523 patients to constitute the baseline
ample. Cases discharged between December 15, 2001 and
arch 31, 2002 with the same inclusion and exclusion
riteria were eligible for “re-measurement.” Cases for both
edicare and non-Medicare groups were identified from
ndividual hospitals. To achieve a similar sample size for
e-measurement, a 95% sample of Medicare cases dis-
harged from the hospital with a valid beneficiary claim
uring the re-measurement period were sampled. For non-
edicare cases, a 50% sample was selected with 20 mini-
um cases per hospital. For re-measurement, 349 Medicare
nd 200 non-Medicare charts were abstracted, and after
able 1. Hospital Characteristics
Hospital Characteristics n
otal 5
eaching hospital/non-teaching 5
arge/moderate/small volume* 3/2/0
acility for CABG/No CABG surgery 4/1
ospitals with 10% minority
patients with acute myocardial
infarction discharge per year
4/5
Based on peer grouping criteria.
CABG  coronary artery bypass graft.
able 2. Patients’ Demographics, Past Medical History, and
linical Features
Characteristics
Baseline
(1/1/2001 to
6/30/2001)
n  523
Re-Measurement
(12/1/2001 to
3/31/2002)
n  499
emographics (%)
Females 43.8 42.7
Non-white 10.3 12.0
Mean age, yrs 66.8 67.5
edical history, n (%)
Hypertension 354 (67.7) 360 (72.1)
Diabetic 175 (33.5) 163 (32.7)
Current smokers 156 (29.8) 151 (30.3)
Previous myocardial infarction 206 (39.4) 194 (38.9)
Previous congestive heart
failure
141 (30.0) 130 (26.1)
Previous coronary bypass
surgery
98 (18.7) 102 (20.4)
Previous percutaneous
coronary intervention
84 (16.1) 94 (18.8)
Previous stroke 83 (15.9) 68 (13.6)
linical, n (%)
Chest pain 438 (83.8) 410 (82.2)
Systolic BP 160 mm Hg or
diastolic BP 100 mm Hg
128 (24.5) 146 (29.3)
Heart rate 100 beats/min 128 (24.5) 105 (21.0)
Discharge home 392 (75.0) 374 (75.1)
Hospital mortality 48 (9.2) 54 (10.8)P  blood pressure.
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June 16, 2004:2166–73 Improving Quality of AMI Carexclusions as previously noted, 499 confirmed cases re-
ained in the post-intervention sample. As in the baseline,
dditional inclusion and exclusion criteria were applied at
he indicator level (1,2,6,7). Medical records for each
ampled hospitalization were copied and forwarded to the
ational CMS clinical data abstraction center. Data were
ollected for each hospitalization, including patient medical
istory, symptoms on arrival, electrocardiographic examina-
ion, in-hospital treatment and events, and discharge treat-
ent and disposition. For quality assurance purposes, data
ere re-abstracted for a random sample of both baseline and
e-measurement records (40 records) by the clinical data
bstraction center. There was an overall reliability of 93.6%
original abstracted data vs. re-abstracted data) and an
ccuracy rate of 96.7% (both original abstracted data and
e-abstracted data compared with “gold standard” data) for
he variables in the abstraction module. Quality of care was
ssessed by measuring the use of key indicators in “ideal
atients” as reported in previous studies (1,2,6,7). Four test
ndicators (indicators that are under development and re-
iew) were also evaluated (1,2,6,7).
able 3. Quality Indicator Rates at Baseline and at Re-Measurem
Quality Indicator
Baseline,
n (% [SD])
n  523
Re
arly aspirin 215/241 (88.9 [2.2]) 170
arly beta-blockers 106/144 (71.8 [4.3]) 88
holesterol measured within 24 h 176/209 (82.3 [3.2]) 158
ischarge aspirin 191/235 (78.8 [3.0]) 190
ischarge beta-blockers 66/84 (78.4 [5.5]) 8
ischarge ACE inhibitors 63/90 (69.2 [5.6]) 5
ischarge treatment of elevated
cholesterol
95/130 (76.8 [3.8]) 115
moking cessation counseling 85/135 (57.5 [4.3]) 93
ietary counseling (%) 309/393 (78.1 [2.2]) 329
For comparison of baseline and remeasurement sample; †for comparison of baseline
ACE  angiotensin-converting enzyme.
able 4. Guidelines Applied in Practice Tool Utilization at
aseline and Re-Measurement
GAP Tool
Utilization
Baseline
(n)
Rate
(%)
Re-Measurement
(n)
Rate
(%)
mergency room
preset orders
0/523 0.0 1/499 0.2
MI standing
orders
67/523 12.8 142/499 28.5
CS standing
orders
289/523 55.3 305/499 61.1
MI or ACS
standing
orders
341/523 65.2 408/499 81.8
linical pathway 313/523 59.8 394/499 79.0
MI specific
discharge
form*
5/405 1.2 179/380 47.1
ny tool used 403/523 77.1 465/499 93.2
Excluding transfers to another acute care facility, expired cases, cases with unknown
ischarge status, terminal illness, or limitation of resuscitation.
ACS  acute coronary syndromes; AMI  acute myocardial infarction; GAP 
puidelines Applied in Practice.tatistical analysis. Data analysis was performed using the
ame algorithm as the one used for CMS’s current national
MI quality indicators (1,2,6,7). Abstracted data were
nalyzed to confirm the presence of an AMI based upon
levated cardiac biomarkers and/or electrocardiographic
nalyses, and/or the presence of chest pain within 48 h of
rrival as reported by earlier studies (1,2,6,7). Additional
ndicator-specific inclusion and exclusion criteria were ap-
lied so that only “ideal” patients remained in the denom-
nators (1,2,6,7). Each quality indicator baseline rate was
ompared with the re-measurement rate for “ideal cases” at
he aggregate and individual hospital level. To measure the
ffect of tool use, baseline rates were also compared with
e-measurement rates for those cases where GAP tools were
easured or referenced in the chart. Because a stratified
ample method was used, aggregate indicator rates were
alculated by weighting hospital-specific rates to reflect each
ospital’s proportion of Medicare and non-Medicare cases
n the combined AMI patient universe.
The statistical tests of comparison at the aggregate level
ere made using two-tailed binomial z test for proportions
p  0.05). Additional analyses were performed to examine
he effect of the quality improvement effort in patients with
nd without percutaneous coronary intervention (PCI) and
atients with and without coronary artery bypass graft
CABG) surgery during their current hospitalization. The
AS version 8.0 (SAS Institute Inc., Cary, North Carolina)
as used for all statistical analysis.
ESULTS
ospital characteristics and patients’ demographic data,
ast medical history, and clinical presentations. We
tudied 1,022 patients, 523 from the baseline period (pre-
ntervention) and 499 from the re-measurement (post-
ntervention) period. The hospital characteristics are shown
n Table 1. The proportion of Medicare patients in baseline
nd re-measurement samples were 62.9% and 62.5%, re-
pectively (p  NS). Most clinical characteristics of the two
(Overall) and With Tool Use
surement
[SD])
499 p Value*
Re-Measurement
With Tool
n (% [SD]) p Value†
89.6 [2.5]) 0.834 147/161 (92.0 [2.3]) 0.330
71.6 [5.5]) 0.977 75/106 (72.0 [5.1]) 0.976
83.6 [3.8]) 0.794 142/162 (86.8 [3.5]) 0.343
90.9 [1.9]) 0.001 95/103 (93.0 [2.6])  0.001
90.4 [3.9]) 0.075 33/37 (89.2 [4.5]) 0.129
88.8 [3.2]) 0.002 31/36 (89.2 [4.6]) 0.006
84.1 [3.1]) 0.137 48/55 (87.2 [4.6]) 0.081
72.8 [4.2]) 0.011 49/56 (87.2 [4.6])  0.001
88.8 [1.7])  0.0001 167/174 (95.6 [1.7])  0.001
emeasurement with tool use.ent
-Mea
n (%
n 
/191 (
/122 (
/187 (
/211 (
0/87 (
2/63 (
/139 (
/128 (
/367 (
and ratient populations were similar (Table 2). The proportion
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Improving Quality of AMI Care June 16, 2004:2166–73f patients discharged to home and the in-hospital mortality
id not differ between the two groups.
mpact of quality improvement initiative on the overall
uality of care. Significant increases in adherence to key
reatments were seen in the discharge treatment indicators
f administration of aspirin at 93.0% (p  0.001),
ngiotensin-converting enzyme (ACE) inhibitors at 89.2%
p  0.006), smoking cessation counseling at 87.2% (p 
.001), and dietary counseling at 95.6% (p  0.001) with
rends for improvement in the other discharge indicators
Table 3). The admission indicator rates were high at
aseline and remained high at re-measurement (Table 3).
o substantive effect on time to reperfusion in ST-segment
levation AMI was observed. However, small sample size
recluded meaningful analyses of this indicator.
ool use and its impact on the quality of care. Evidence
f utilization of at least one tool was present in 93.2% of
he records at re-measurement (Table 4). All five hospi-
als were using standard admission orders for most
atients with acute coronary syndromes at baseline. The
resence of preset admission orders was identified in the
ecords of 65.2% of patients at baseline and 81.8% at
e-measurement. Clinical pathways were used in 59.8%
nd 79.0% of the cases at baseline and re-measurement,
espectively. The AMI specific discharge tool, developed
or this project, was evident in 47.1% of patients at
e-measurement.
When standard orders were used, a high rate of adher-
nce to the use of admission aspirin, beta-blockers, and
easurement of cholesterol panel within 24 h was observed.
Table 5. Quality of Care in Patients Undergoi
Quality Indicators
Re-Measurem
PCI Numera
Denominat
(%) [SD]
Discharge aspirin 102/110 (92%) [2
Discharge beta-blockers 44/45 (98.7%)
Discharge ACE inhibitors 20/22 (92.9%)
Discharge treatment of
elevated cholesterol
58/62 (94.5%)
Smoking cessation
counseling
57/65 (87.8%)
Dietary counseling (%) 172/178 (96.5%)
ACE  angiotensin-converting enzyme; PCI  percutaneo
able 6. Quality of Care in Patients Undergoing CABG Surgery
Quality Indicators
Re-Measurement
CABG
(n)
Re-Meas
CA
(% [S
ischarge aspirin 24/29 83.2 (
ischarge beta-blockers 9/11 84.8 (
ischarge ACE inhibitors 4/8 44.2 (
ischarge treatment of
elevated cholesterol
8/14 53.1 (
moking cessation counseling 14/18 77.1 (
ietary counseling (%) 45/50 90.1 (CE  angiotensin-converting enzyme; CABG  coronary artery bypass graft.ecause admission orders were widely used before this
nitiative, the admission indicator rates, although higher
han baseline for all indicators, were not statistically higher
n the re-measurement sample (Table 3). In contrast, the
se of a standard discharge tool was associated with in-
reases (or a trend towards increase) in all discharge indi-
ators including aspirin (p  0.001), beta-blockers (p 
.129), ACE inhibitors (p  0.006), treatment of elevated
holesterol (p  0.081), and smoking cessation (p  0.001)
nd dietary counseling (p  0.001) (Table 3).
uality indicator rates in patients undergoing percuta-
eous interventions or CABG. Percutaneous coronary
ntervention or CABG was performed in 200 (40.1%) and
7 (11.4%) of patients during hospitalization, respectively.
ates of discharge indicators in PCI patients were higher
han in those not undergoing PCI (Table 5). In contrast, the
se of discharge aspirin, beta-blockers, ACE inhibitors, and
reatment for elevated cholesterol was lower in patients
ndergoing CABG. Smoking cessation and dietary coun-
eling were offered to similar proportions of patients in the
ABG and no-CABG group (Table 6).
ISCUSSION
his study demonstrates that the implementation of tools of
MI care was increased across five hospitals when a major
mphasis was placed on monitoring and increasing their
tilization. Use of care tools was associated with increases in
dherence to the key quality of care indicators for AMI care.
ogether with previous reports (2,4), our results suggest
CI
Re-Measurement
No PCI Numerator/
Denominator
(%) [SD] p Value
58/65 (89.1%) [4.0] 0.415
23/25 (93.3%) [4.8] 0.278
28/31 (91.6%) [4.9] 0.854
43/53 (81.2%) [5.6] 0.031
17/38 (44.7%) [8.5]  0.001
112/139 (81.0%) [3.6]  0.001
nary intervention.
ent Re-Measurement
No CABG
(n)
Re-Measurement
No CABG
(% [SD]) p Value
160/175 91.3 (2.2) 0.225
67/70 96.3 (2.2) 0.301
49/53 92.0 (3.8)  0.001
101/115 87.9 (3.1) 0.050
74/103 71.5 (4.5) 0.635
265/294 90.1 (1.7) 1.000ng P
ent
tor/
or
.4]
[1.3]
[5.1]
[2.6]
[4.2]
[1.4]urem
BG
D])
6.3)
10.9)
5.9)
17.5)
10.9)
4.1)
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June 16, 2004:2166–73 Improving Quality of AMI Carehat the routine use of care tools is an effective method of
eminding caregivers and patients regarding key priorities in
MI care.
Knowledge of or even implementation of national guide-
ines (3) meant to alter physician behavior often yields
isappointing results (6–16). The clinical care tools for
MI described in this study attempted to encourage a
tandardized clinical approach to the management of AMI
ictims and served as an important reminder as to the goals
f care. This “simple,” multifaceted approach to improving
uality of AMI care, focused on caregivers and patients,
upported by the national guidelines, and endorsed by local
Table 7. Barriers to the Use of Tools/Strategie
Barrier
Planning
Lengthy approval processes for new forms,
threatening start date and time line.
Education
Difficulty reaching all medical staff
(cardiologists, emergency department,
internist, family practice, and so forth) for
project recruitment, education, and feedback
after implementation.
Difficulty reaching all nursing and ancillary staff
(critical care units, emergency department,
general units, off shifts, and the like) for
project recruitment, education, and feedback
after implementation.
Implementation
Physicians resistant to use standing orders.
Nurses resistant to use new discharge form.
Monitoring Tool Use
Difficulty identifying concurrent AMI sample
to review charts for tool use.
Re-Measurement
Medical records process of coding and closing
charts was lengthy, with delays when
physicians still needed to dictate or sign
records.
AMI acute myocardial infarction; CME continuing med
Applied in Practice.hysicians and opinion leaders, resulted in improved adher- ence to key quality indicators. By directing the focus on
rocesses of care and tool use rather than focusing solely on
he key indicators, we achieved higher utilization of tools
han observed in the previous study (2) with resultant
mprovement in quality of AMI care.
Both approaches (tracking adherence to key indicators vs.
n emphasis on tool use) are relevant to effective improve-
ent in adherence to key quality indicators. However,
onitoring of tool use acknowledges that the development
f a sustained process of care (or system) that is triggered by
he admission of a patient may be more effective than
elying on a consistent memory of caregivers in rendering
Overcome Barriers
Strategies
Used a revised approach to customize forms.
Physician champions to accelerate the
process.
Labeled the project a “pilot” until results
were available, accelerating acceptance.
Scheduled CME presentations to coincide
with existing medical staff meetings, and
invited other disciplines/house officers to
the meeting.
Supplied samples of new forms and
information fliers at all locations.
Included GAP as an agenda item at medical
staff meetings with short, concise updates.
Created one-page informational sheets to
capture attention.
Communicated via mass phone mail
messages, e-mails, and articles in staff
newsletters.
Provided continuing educational
presentations at regular staff meetings for
nursing and ancillary staff.
Identified/trained key nursing support staff
(case managers, advance nurse
practitioners, unit charge nurses, discharge
coordinators, CNS group, and others) to
promote GAP, educate staff, and conduct
follow-up discussions for all shifts.
Used volunteers to assist with promotional
materials and roll out activities.
Provided one-on-one follow-up by physician
champion and nurse managers stressing
the importance of tools for improving
quality.
Created sample from list of patients with
elevated troponins generated by hospitals’
laboratory.
Involved medical records staff and coders in
designing rapid process to meet
remeasurement time line. Gave special
feedback to physicians at meetings.
ucation; CNS central nervous system; GAPGuideliness to
ical edvidence-based care. We believe that focusing on improved
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Improving Quality of AMI Care June 16, 2004:2166–73ool use translates directly to improved indicator rates if
here has been broad institutional buy-in and support. Also,
t is possible for a clerk or other staff member to track tool
se, whereas monitoring of the key indicators themselves
equires a clinician with broad knowledge of the indications
nd contraindications for each measure.
Our study provides several insights that may be useful in
uture initiatives aimed at quality improvement. First, de-
pite the collaborators’ best efforts, some of the tools
particularly the discharge document) were not utilized in all
atients. To be able to gain better insights into factors
elated to resistance for tool use for AMI care, we prospec-
ively tracked perceived barriers to their utilization. We
dentified multiple barriers during the project and some of
ur strategies to overcome them (Table 7). Second, our
tudy identified a clinical subgroup that may have greater
otential for improvement in care after AMI. Patients
ndergoing CABG were less likely to receive aspirin,
eta-blockers, ACE inhibitors, and cholesterol-lowering
gents at discharge (Table 6). Physicians’ ambivalence about
sing beta-blockers, ACE inhibitors, and statins in patients
fter CABG may stem from the lack of specific randomized
rials supporting their use in post-CABG patients. How-
ver, because patients with AMI in general benefit from the
se of evidence-based medicines, and because data from
bservational studies support use in post-CABG patients
17,18), their use among ideal patients is generally endorsed
y the national guidelines.
In contrast to patients undergoing CABG, those under-
oing PCI were more likely to receive most key indicators
nown to improve survival in these patients (Table 5).
everal factors may account for this, including younger age
f the patients, more frequent use of standardized protocols
or their care, and physicians and staff who were more aware
f the guideline initiative and its importance.
In the era of growing national focus on quality in health
are together with the recognition that important gaps exist
6–16), strategies such as the ACC GAP initiatives may
rovide a roadmap to improving quality of care across the
ation (19). Medicine by memory is not reliable. Focusing
s much on the use of a care system, rather than simply on
ndicators themselves, represents an additional step that will
mprove performance. Institutions and caregivers should
mbrace these strategies in caring for patients with AMI as
e attempt to realize the target of “Healthy People 2010”
20).
tudy limitations. This study was an observational cohort
tudy which used each hospital’s previous performance as
he control against which improvement was measured.
ecause there has been a general improvement in quality
ndicators in recent years, it is not possible for us to
etermine how much improvement stemmed from GAP
ersus secular trends. However, in the ACC GAP pilot, we
howed that improvement in quality indicators was more
ubstantial in the 10 hospitals that participated in the GAP
roject than in “control” hospitals that volunteered toarticipate but were not chosen (2). Second, we analyzed
uality indicator rates in “ideal” patients only. There are
any patients with relative contraindications to key thera-
ies who may also benefit from them. Third, because we
tudied care in just five hospitals in two Michigan commu-
ities, the generalizability of our results to other regions or
are environments is not possible. Finally, although we
elieve that this study, as well as the GAP Pilot Project,
emonstrates the potential to improve hospital AMI care by
mbedding key therapeutic targets into the care itself, the
ustainability of this improvement after discharge is un-
roven and needs to be studied.
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